혈액 가스 및 전해질 분석기 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the global blood gas and electrolyte analyzer market size was valued at USD 2.65 billion in 2025 and estimated to grow from USD 2.79 billion in 2026 to reach USD 3.62 billion by 2031, at a CAGR of 5.34% during the forecast period (2026-2031).

This report is Segmented by Product Type (Instruments [Blood Gas Analyzer, and More] and Consumables), Modality Type (Benchtop Systems, Portable /Hand-Held Systems), Technology (Cartridge-Based, Electrochemical Sensor and More), End User (Hospital Central Laboratories, and Others), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Blood Gas And Electrolyte Analyzer Market Trends and Insights

Growing Adoption of Critical-Care Point-of-Care Testing

Bedside analyzers now deliver arterial pH, PaO2, PaCO2, electrolytes, and lactate results in under a minute, compressing decision cycles for sepsis bundles, ventilator adjustments, and trauma resuscitation. Systems such as the epoc Blood Analysis System integrate Wi-Fi modules so data flows directly into electronic medical records, eliminating manual transcription errors and cutting laboratory workload.Lower turnaround times translate into documented cost avoidance: a pediatric ICU reduced daily test frequency by 53% and saved USD 19,068 annually after deploying stewardship protocols around point-of-care blood-gas devices journals. Emergency departments also benefit, where 60-second results support prompt stroke differentiation before radiology confirmation.

Rapid Rise in COPD & Asthma Admissions in Megacities

Ambient air pollution, aging populations, and high smoking prevalence are driving COPD burdens toward low- and middle-income economies; 90% of COPD deaths now arise in those settings . Metropolitan hospitals facing surges of acute exacerbations require on-site blood-gas capacity to titrate oxygen therapy and non-invasive ventilation. Manufacturers are releasing ruggedized analyzers with battery backup and climate-tolerant sensors for secondary-level facilities lacking stable power. Expanded access improves triage accuracy, shortens emergency room dwell time, and can curb readmission penalties tied to respiratory care pathways.

Capital-Budget Constraints

Capital scarcity after pandemic procurement spikes forces hospitals to defer analyzer refresh cycles. The U.S. Department of Health and Human Services documented sharp price surges for critical devices, squeezing budgets and shifting preference to reagent-rental or pay-per-test contracts that lift upfront cost barriers. Vendors respond by bundling service, QC cartridges, and analytics dashboards under operating-expense models, aligning with finance teams that favor predictable monthly cash flows.

Other drivers and restraints analyzed in the detailed report include:

1. Integration of IoT-Enabled Benchtop Analyzers Accelerating Lab Automation
2. Technological Advancements in Blood Gas and Electrolyte Analyzers
3. Issues Regarding Regulation and Reimbursement of ABG Tests

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Consumables contributed 58.12% to the blood gas and electrolyte analyzer market in 2025, underlining the razor-razorblade model that anchors vendor revenue stability. Each arterial or venous sample draws a single-use cartridge, electrode pack, or reagent ampoule, turning high test frequency in critical-care beds into recurring cash flow. Masimo demonstrates the model: 89% of its healthcare revenue comes from consumables and services, financing R&D cycles that feed next-generation platforms. Integrated reagent-QC pouches also reduce inventory complexity and environmental exposure, lifting shelf life-an attractive feature for resource-limited facilities.

Electrolyte analyzers display a 5.82% CAGR through 2031 as outpatient chronic-disease clinics, dialysis centers, and sports-medicine programs seek compact devices that report sodium, potassium, chloride, ionized calcium, and glucose within two minutes. The segment overlays growth of combined analyzers that merge gases, metabolites, CO-oximetry, and electrolytes in one platform, shrinking blood draw volumes-a decisive point for neonatal wards. Nova Biomedical's micro-sample mode demonstrates how microfluidics and intelligent fluidics engineering can fit an 11-test panel into 90 µL, linking clinical benefit to lower total cost of ownership news-medical.net. As a result, the blood gas and electrolyte analyzer market size for electrolyte-focused devices is forecast to command material share gains over the decade.

Benchtop analyzers retained 50.35% of global revenue in 2025 thanks to throughput, extended menus, and middleware hooks that central labs require. Dark-lab architecture integrates these analyzers with track systems and robotic arms, pushing unattended overnight operation to new levels mlo-online.com. Hospitals value long-term reagent contracts and consolidated QC regimes that stabilize per-test economics.

Portable and handheld platforms, however, are increasing at a 7.12% CAGR. Ambulance crews deploy battery-powered analyzers alongside defibrillators, capturing pH and lactate en-route to trauma centers, enabling physicians to pre-activate massive transfusion protocols. In operating rooms, anesthesiologists place palm-sized devices on the instrument table to fine-tune ventilation during thoracic surgery. Because these handhelds upload results via Bluetooth or hospital Wi-Fi, they integrate into lab reports without extra clerical work, making them pivotal to the decentralization wave sweeping the blood gas and electrolyte analyzer market.

Complete Report Scope:

• By Product Type (Value)
  • Instruments
    • Blood Gas Analyzer
    • Electrolyte Analyzer
    • Combined Blood Gas & Electrolyte Analyzer
  • Consumables (Cartridges, Reagents & Sensor Strips)
• By Modality (Value)
  • Benchtop Systems
  • Portable / Hand-Held Systems
• By Technology (Value)
  • Cartridge-Based
  • Electrochemical Sensor
  • Optical / Optode
  • Others (Ion-Selective Electrode, Fluorescent)
• By End-User (Value)
  • Hospital Central Laboratories
  • Point-of-Care Testing within Hospitals
  • Ambulance & Emergency Medical Services
  • Diagnostic Laboratories & Clinics
  • Home Healthcare Settings
• By Geography (Value)
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia- Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America generated 38.12% of global revenue in 2025, anchored by dense ICU bed stock, reimbursement for respiratory diagnostics, and extensive provider networks. The blood gas and electrolyte analyzer market size for the region stays buoyant as consolidation, exemplified by BD's USD 4.2 billion purchase of Edwards Lifesciences' Critical Care Unit, adds connected-care capabilities to corporate portfolios. Nevertheless, laboratory retirement waves threaten capacity; 18.9% vacancy in blood-bank brethren spills over to critical-care labs, prompting health systems to favor analyzers with walk-away operation.

Asia-Pacific is forecast to post a 7.14% CAGR to 2031, narrowing the gap through public hospital expansion, private sector build-out, and government programs that subsidize diagnostic equipment for lower-tier cities. Urban smog adds to COPD caseloads, swelling arterial blood-gas demand. Domestic manufacturing initiatives encourage localization of cartridges and sensors, trimming import duties and strengthening supply resilience. As a result, the blood gas and electrolyte analyzer market in Asia-Pacific is transitioning from import-dependent to hybrid supply chains, accelerating price-point convergence with Western markets.

Europe retains a solid revenue base thanks to early technology uptake, stringent QC standards, and centralized procurement that negotiates large reagent volumes. Growth is steadier than in emerging regions but benefits from rising adoption of handheld analyzers in ambulance fleets aligned with pan-European emergency-medical-services guidelines.

Latin America and the Middle East & Africa together represent modest but accelerating slices of the blood gas and electrolyte analyzer market. Gulf countries channel oil surpluses into tertiary-care complexes that specify analyzers with Arabic user interfaces, while Brazilian private chains upgrade labs to manage a growing cardiovascular burden. Vendor differentiation increasingly depends on training hubs, local-language software, and heat-tolerant cartridges that sustain performance above 35 °C.

1. Radiometer Medical ApS (Danaher)
2. Siemens Healthineers
3. Abbott Laboratories
4. F. Hoffmann-La Roche AG (Roche Diagnostics)
5. Nova Biomedical
6. Medica Corporation
7. Sensa Core
8. Nihon Kohden
9. Eschweiler GmbH
10. Grifols
11. Arkray
12. OPTI Medical (IDEXX)
13. Convergent Technologies
14. EKF Diagnostics
15. PHC Holdings (Ascensia)
16. WerfenLife Diagnostics China
17. Terumo Cardiovascular
18. Edan Instruments
19. Sphere Medical
20. Brolis Sensor Technology
21. Balio Diagnostics
22. Trinity Biotech plc

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Adoption of Critical-Care POC Testing
  • 4.2.2 Rapid Rise in COPD & Asthma Admissions in Megacities
  • 4.2.3 Increasing Neonatal ICU Births Requiring Frequent Arterial Blood-Gas Monitoring
  • 4.2.4 Integration of IoT-Enabled Benchtop Analyzers Accelerating Lab Automation
  • 4.2.5 Technological Advancements in Blood Gas & Electrolyte Analyzers
• 4.3 Market Restraints
  • 4.3.1 Capital-Budget Constraints in Public & Small-Size Hospitals
  • 4.3.2 Issues Regarding Regulation and Reimbursement of ABG Tests
  • 4.3.3 Skilled-Operator Shortage Hindering Adoption of Combined Systems
  • 4.3.4 Accuracy Concerns with Disposable Sensor Strips in Low-Cost Devices
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Outlook
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type (Value)
  • 5.1.1 Instruments
    • 5.1.1.1 Blood Gas Analyzer
    • 5.1.1.2 Electrolyte Analyzer
    • 5.1.1.3 Combined Blood Gas & Electrolyte Analyzer
  • 5.1.2 Consumables (Cartridges, Reagents & Sensor Strips)
• 5.2 By Modality (Value)
  • 5.2.1 Benchtop Systems
  • 5.2.2 Portable / Hand-Held Systems
• 5.3 By Technology (Value)
  • 5.3.1 Cartridge-Based
  • 5.3.2 Electrochemical Sensor
  • 5.3.3 Optical / Optode
  • 5.3.4 Others (Ion-Selective Electrode, Fluorescent)
• 5.4 By End-User (Value)
  • 5.4.1 Hospital Central Laboratories
  • 5.4.2 Point-of-Care Testing within Hospitals
  • 5.4.3 Ambulance & Emergency Medical Services
  • 5.4.4 Diagnostic Laboratories & Clinics
  • 5.4.5 Home Healthcare Settings
• 5.5 By Geography (Value)
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia- Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Radiometer Medical ApS (Danaher)
  • 6.3.2 Siemens Healthineers AG
  • 6.3.3 Abbott Laboratories
  • 6.3.4 F. Hoffmann-La Roche AG (Roche Diagnostics)
  • 6.3.5 Nova Biomedical
  • 6.3.6 Medica Corporation
  • 6.3.7 Sensa Core
  • 6.3.8 Nihon Kohden
  • 6.3.9 Eschweiler GmbH
  • 6.3.10 Grifols
  • 6.3.11 ARKRAY Inc.
  • 6.3.12 OPTI Medical (IDEXX)
  • 6.3.13 Convergent Technologies
  • 6.3.14 EKF Diagnostics
  • 6.3.15 PHC Holdings (Ascensia)
  • 6.3.16 WerfenLife Diagnostics China
  • 6.3.17 Terumo Cardiovascular
  • 6.3.18 Edan Instruments
  • 6.3.19 Sphere Medical
  • 6.3.20 Brolis Sensor Technology
  • 6.3.21 Balio Diagnostics
  • 6.3.22 Trinity Biotech plc

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment